A detailed history of Kelly Lawrence W & Associates Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 1,075 shares of ZTS stock, worth $192,113. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,075
Previous 1,075 -0.0%
Holding current value
$192,113
Previous $186,000 12.9%
% of portfolio
0.05%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $137,808 - $162,106
957 Added 811.02%
1,075 $169,000
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $161,467 - $179,231
-1,028 Reduced 89.7%
118 $20,000
Q3 2017

Nov 15, 2017

BUY
$59.73 - $65.4 $68,450 - $74,948
1,146
1,146 $74,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Kelly Lawrence W & Associates Inc Portfolio

Follow Kelly Lawrence W & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.